ARCHIVES

NCI Should Examine Alternative Therapies TA Report Says

This article is from The Cancer Letter archive.

Vol. 16 No. 37 | September 28, 1990

Download PDF Visit The Full Archive

Related Articles

Banned Investigator Plans To Resume Clinical Trials Role

August 10, 1990

In Brief: On “Clouds Of glory,” And An Italian Bike, Varmus Takes Office As 14th NIH Director

November 26, 1993

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

Research Funding: 30 Groups Sign Letter For Double NCI Budget

January 23, 1998

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002